➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Boehringer Ingelheim
Merck
Harvard Business School
Dow

Last Updated: June 6, 2020

DrugPatentWatch Database Preview

Bedford Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for BEDFORD, and what generic and branded alternatives to BEDFORD drugs are available?

BEDFORD has twenty-nine approved drugs.

There are five tentative approvals on BEDFORD drugs.

Summary for Bedford
US Patents:0
Tradenames:22
Ingredients:19
NDAs:29
Patent Litigation for Bedford: See patent lawsuits for Bedford

Drugs and US Patents for Bedford

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bedford CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 062894-001 Jul 21, 1988 DISCN No No   Start Trial   Start Trial
Bedford CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065465-003 Aug 18, 2008 DISCN No No   Start Trial   Start Trial
Bedford NEOSAR cyclophosphamide INJECTABLE;INJECTION 087442-004 Jul 8, 1983 DISCN No No   Start Trial   Start Trial
Bedford CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065465-002 Aug 18, 2008 DISCN No No   Start Trial   Start Trial
Bedford SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim INJECTABLE;INJECTION 072383-001 Apr 29, 1992 DISCN No No   Start Trial   Start Trial
Bedford OFLOXACIN ofloxacin INJECTABLE;INJECTION 075762-001 Jan 16, 2002 DISCN No No   Start Trial   Start Trial
Bedford CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 062894-005 Jul 21, 1988 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Harvard Business School
Dow
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.